Penn State is a clinical research site located in Hershey, Pennsylvania, United States 17033.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Penn State has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Acquired Hemophilia A, Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Bicuspid Aortic Valve.
Sponsors: Baxalta now part of Shire, MeiraGTx, LLC, Oregon Health and Science University.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Penn State has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Penn State has 6 clinical trials on record, with 1 currently active. Their work covers Acquired Hemophilia A, Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Bicuspid Aortic Valve.
Yes — Penn State holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.